What Primary Care Physicians Need to Know about Once-Weekly Insulin

As insulin therapies evolve, once-weekly formulations are emerging as a promising option for patients with type 2 diabetes (T2D). This session will equip primary care clinicians with the tools to initiate basal insulin therapy promptly and appropriately, avoiding unnecessary delays in care. Dr. Miller will review the latest clinical data on the efficacy and safety of new and emerging ultra-long acting, once-weekly insulins, and offer practical comparisons to traditional daily basal insulin options. Attendees will gain insights into how these innovations may improve adherence, simplify regimens, and impact patient outcomes.